Insulet Corp: Form 10-K for the period ended Dec 31, 2019
Filed with the SEC on Feb 26, 2020 and accepted by EDGAR at Feb 25, 2020, 19:39 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-10-01 to 2019-12-31 | $209.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 12 months2019-01-01 to 2019-12-31 | $738.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2019-01-01 to 2019-12-31 | $257.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2019-10-01 to 2019-12-31 | $134.1m | us-gaap:GrossProfit |
| Gross profit | 12 months2019-01-01 to 2019-12-31 | $480.3m | us-gaap:GrossProfit |
| Research and development | 12 months2019-01-01 to 2019-12-31 | $129.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2019-01-01 to 2019-12-31 | $50.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2019-01-01 to 2019-12-31 | $34.6m | us-gaap:InterestExpense |
| Income tax | 12 months2019-01-01 to 2019-12-31 | $2.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-10-01 to 2019-12-31 | $5.0m | us-gaap:NetIncomeLoss |
| Net income | 12 months2019-01-01 to 2019-12-31 | $11.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-10-01 to 2019-12-31 | $0.08 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2019-01-01 to 2019-12-31 | $0.19 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-10-01 to 2019-12-31 | $0.08 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2019-01-01 to 2019-12-31 | $0.19 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2019-01-01 to 2019-12-31 | 62,304,348 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2019-01-01 to 2019-12-31 | $98.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2019-01-01 to 2019-12-31 | $163.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2019-12-31 | $213.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-12-31 | $591.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-12-31 | $1.14bn | us-gaap:Assets |
| Current liabilities | At period end2019-12-31 | $157.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-12-31 | $1.07bn | us-gaap:Liabilities |
| Long-term debt | At period end2019-12-31 | $887.9m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2019-12-31 | $75.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001145197-20-000004. Last ingested by Listed: Nov 4, 2026, 16:38 ET. Listed shows no prices and gives no investment advice.